[OPB-9195].
Takeuchi
Masayoshi
M
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokuriku University.
Yamagishi
Sho-ichi
S
Makita
Zenji
Z
D000818:Animals; D003925:Diabetic Angiopathies / Q000188:drug therapy / Q000209:etiology; D004195:Disease Models, Animal; D015195:Drug Design; D017127:Glycation End Products, Advanced / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006146:Guanidines / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D013830:Thiadiazoles / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use; D053778:Thiazolidines
D017127:Glycation End Products, Advanced; D006146:Guanidines; D007004:Hypoglycemic Agents; C101705:N-phenacylthiazolium bromide; C105739:OPB 9195; D013830:Thiadiazoles; D013844:Thiazoles; D053778:Thiazolidines; C004479:pimagedine